
|Videos|February 17, 2023
Summary and Case Study
Centering focus on a patient case of cardiovascular risk and prostate cancer, experts share their perspective on management strategies.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Focal therapy for prostate cancer frequently used outside guideline-supported groups
2
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
3
Published LITESPARK-011 data show PFS benefit with belzutifan plus lenvatinib in ccRCC
4
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
5















